Clinical trial / 2011
Bioavailability of sulforaphane and erucin was dramatically lower from a broccoli supplement than from fresh broccoli sprouts in human subjects.
In a crossover study, 12 subjects consumed 40 g of fresh broccoli sprouts followed by a 1-month washout, and then consumed 6 pills of a broccoli supplement (with 4 additional subjects serving as negative controls receiving alfalfa sprouts and placebo). Blood and urine were collected over 48 hours to measure sulforaphane and erucin metabolites. Bioavailability was dramatically lower, and peak plasma concentrations and urinary excretion were delayed, following the broccoli supplement compared to fresh broccoli sprouts. In vivo interconversion between sulforaphane and erucin occurred consistently within subjects but varied between subjects, while GSTP1 polymorphisms did not affect metabolism or excretion.
- Study type
- Crossover study
- Who was studied
- 12 human subjects (plus 4 negative controls)
- What was measured
- Bioavailability, plasma concentrations, and urinary excretion of sulforaphane and erucin metabolites over 48 hours
THE PAPER
Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design.
Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, Stevens JF, Ho E. Pharmacol Res, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.